The COVID-19 pandemic created ripple effects across all of health care, especially for at-risk populations like cancer patients. Early in the pandemic, the National Cancer Institute initiated a study to examine the intersection of cancer and COVID-19 diagnoses. More than two years later, we discuss with NCI Head of Breast Cancer and Melanoma Therapeutics Dr. Larissa Korde from the Clinical Investigations Branch on the status of the study, some of the preliminary findings and how it’s evolved.
Cancer HealthCast
26m listen
A Look Into COVID-19’s Impact on Cancer Patients
Share
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
-
Dr. Larissa Korde Head, Breast Cancer and Melanoma Therapeutics NCI
Related Content
-
Marne Innovation Center Empowers Soldiers to Solve Battlefield Challenges
The Army’s Marne Innovation Center is transforming battlefield efficiency by sourcing real-time problems and solutions directly.
12m listen -
From Fed to Founder: Joe Scheidler on People, Policy, Innovation
Joe Scheidler outlined lessons from his White House and State Department tenure that helped drive his startup success.
7m watch -
IHS Modernizes Native Health Care with PATH EHR
IHS CIO Mitchell Thornbrugh shares how PATH EHR is transforming Native health care through data liberation, scalable systems and community-driven innovation.
18m listen -
From FedRAMP to Industry: Tips for Successful Career Transitions
Former FedRAMP head Brian Conrad discusses his transition experiences from government and industry to continue serving the mission.
6m watch
